Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding XBiotech Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of XBIT: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders6661−5
Shares4.71M4.21M−500.8K (−10.6%)
Value$56.7M$46.8M−$9.91M (−17.5%)

New holders (11)

Institutions that held XBiotech Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to XBIT in Q4 2021
InstitutionSharesValue% of portfolio
Allspring Global Investments Holdings, LLC59,141$658.0K0.00%
Marshall Wace, LLP24,176$269.0K0.00%
Trexquant Investment LP20,648$230.0K0.01%
Ergoteles LLC14,200$158.0K0.01%
Alberta Investment Management Corp11,300$126.0K0.00%
LGT Fund Management Co Ltd.10,000$111.0K0.03%
High Net Worth Advisory Group LLC1,500$17.0K0.01%
Financial Connections Group, Inc.500$5.00K0.00%
Advisor Group Holdings, Inc.50$1.00K0.00%
Toronto Dominion Bank2$00.00%
Captrust Financial Advisors21$00.00%

Sold out (16)

Institutions that held XBiotech Inc. at the end of Q3 2021 and filed for Q4 2021 without it.